United EcoEnergy Corp. (OTCBB: UEEC), a healthcare solutions and product development company focusing on the expanding wound-care industry, announces the availability of a new online Investor Fact Sheet. “As part of our goal in keeping investors informed with the latest developments at the Company, we are releasing our new fact sheet, which we plan to update frequently,” said Kelly T. Hickel, Chairman and CEO of United EcoEnergy Corp. “We are positioning United to take advantage of the healthcare industry’s growing demand for effective wound-care products through the distribution of an innovative hemostatic gauze, which stops bleeding by forming into a gel-like substance upon contact with blood.” Mr. Hickel continued, “We believe our proprietary hemostatic gauze is poised for significant growth across various applications in the dental, EMS, trauma, and military sectors, and we look forward to providing notable updates on our progress over the coming weeks and months.” The Investor Fact Sheet provides a concise overview of the United EcoEnergy’s business plan and its growth potential in the healthcare market, and is an excellent resource for loyal shareholders and prospective investors alike. The Fact Sheet is available at: www.trilogy-capital.com/autoir/ueec_autoir.html United EcoEnergy and its wholly-owned subsidiary, Epic Wound Care Inc., are penetrating the growing wound-care market by manufacturing an innovative gauze that changes the way medical professionals treat their patients. Upon contact with blood, the gauze forms a gel-like substance, which acts as a hemostatic agent that expands slightly to cause direct pressure on blood vessels and control bleeding. The unique formulation contains no chemical additives and is hypoallergenic. About United EcoEnergy Corp. United EcoEnergy Corp. is a healthcare solutions company that has developed an innovative hemostatic gauze product that stops bleeding by forming into a gel-like substance upon contact with blood. The gauze was initially developed as a tool to provide medical professionals the ability to stop bleeding in the most efficient manner possible. Through the acquisition of intellectual property rights in 2009, Epic Wound Care and its master distributor Coreva Health Science, LLC, have the potential to transform segments of the market such as ambulatory emergencies, surgery, dental, home care and athletic injuries. United’s wholly-owned subsidiary, Epic Wound Care Inc., has been able to penetrate the growing wound-care market by introducing this innovative gauze product and changing the way medical professionals treat their patients. The product is currently being marketed in North America and around the world under the registered brand names: ActCel Gauze, ActJel Gauze, HemoStyp™, and ABC Gauze (which stands for Advanced Bleeding Control™).